Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

29 juin 2026 17h30 HE | Source: PetVivo Holdings, Inc.

PetVivo Reports Financial and Operational Results for Fiscal 2026

MINNEAPOLIS, MN, US, June 29, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV) (OTCID: PETVW), in cooperation with its wholly-owned subsidiaries, Cosmeta Corp, PetVivo Animal Health,...
25 juin 2026 16h04 HE | Source: PetVivo Holdings, Inc.

PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE YEAR 2026 ENDED MARCH 31, 2026

MINNEAPOLIS, MN, US, June 25, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV) (OTCID: PETVW), in cooperation with its wholly-owned subsidiaries, Cosmeta Corp, PetVivo Animal Health,...
24 juin 2026 07h00 HE | Source: PetVivo Holdings, Inc.

PetVivo Holdings Announces Transformative Acquisition Of PiezoBioMembrane To Build a Leading Functional Biomaterials Platform

Acquisition Strengthens Company's Intellectual Property Portfolio and Creates New Opportunities for Medical Device and Therapeutic Product Development Across Animal and Human Health Markets ...
08 juin 2026 14h55 HE | Source: PetVivo Holdings, Inc.

PetVivo Holdings, Inc. to Host Virtual Investor Event

Virtual investor event scheduled for Tuesday, June 16, 2026, at 1 p.m. ET MINNEAPOLIS, MN, US, June 08, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV) (OTCID: PETVW), in cooperation...
11 mai 2026 10h54 HE | Source: Research and Markets

Lecanemab Injection Market Report 2026: Increasing Adoption of Monoclonal Antibody Therapies and Rising Focus on Early Alzheimer's Intervention - Global Long-term Forecasts to 2030 and 2035

Dublin, May 11, 2026 (GLOBE NEWSWIRE) -- The "Lecanemab Injection Market Report 2026" has been added to ResearchAndMarkets.com's offering. The Lecanemab Injection Market Global Report 2026...
01 avr. 2026 06h36 HE | Source: Research and Markets

Rapid Growth in Paclitaxel Injection Market: From $7.68 Billion in 2026 to $12.72 Billion by 2030

Dublin, April 01, 2026 (GLOBE NEWSWIRE) -- The "Paclitaxel Injection Market Report 2026" has been added to ResearchAndMarkets.com's offering. The paclitaxel injection market is on an upward...
25 févr. 2026 09h51 HE | Source: Research and Markets

Prefilled Syringes Market Analysis Report 2026-2031: Rising Self-Injection of GLP-1 Obesity Drugs, Shift to Biologic-Friendly COP Syringes, Glass Delamination Recalls in High-pH Biologics

Dublin, Feb. 25, 2026 (GLOBE NEWSWIRE) -- The "Prefilled Syringes - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's...
17 févr. 2026 16h30 HE | Source: PetVivo Holdings, Inc.

PetVivo Reports Results for Third Quarter and First Nine Months of Fiscal 2026

MINNEAPOLIS, MN, US, Feb. 17, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV; OTC ID: PETVW), and its wholly owned subsidiaries PetVivo Animal Health and PetVivo AI, a leading...
17 févr. 2026 10h32 HE | Source: Research and Markets

Facial Injectable Analysis Report 2025: An $18.89 Billion Market by 2029, Driven by New Product Launches, Emerging Markets, AI Innovations, Male Aesthetics, Younger Demographics

Dublin, Feb. 17, 2026 (GLOBE NEWSWIRE) -- The "Facial Injectable Market: 2025 Edition" report has been added to ResearchAndMarkets.com's offering.In 2023, the global facial injectables market was...
10 févr. 2026 16h22 HE | Source: PetVivo Holdings, Inc.

PetVivo Issues Correction and Replacement Press Release; Sets Fiscal Third Quarter 2026 Conference Call for Tuesday, February 17, 2026 at 5:00 p.m. ET

MINNEAPOLIS, MN, US, Feb. 10, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc., in collaboration with its wholly-owned subsidiary PetVivo Animal Health (OTCQX: PETV; OTCID: PETVW), a leading...

Page suivante